LH · XBRL financial data

Labcorp Holdings financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (LH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2021Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	13,979	16,121	14,877	12,162	13,009	13,952
Cost of revenue	9,026	10,497	10,492	8,797	9,385	9,939
Gross profit	4,953	5,624	4,385	3,365	3,624	4,013
Selling, general and administrative	1,729	1,952	1,997	2,021	2,230	2,216
Operating income (loss)	2,445	3,260	1,774	726	1,087	1,385
Interest expense	207	212	180	200	208	224
Other income (expense)	(32)	43	(25)	16	60	(55)
Income tax expense (benefit)	662	747	302	189	212	230
Net income (loss)	1,556	2,377	1,279	418	746	877
Earnings per share, basic USD per share	15.99	24.60	14.05	4.80	8.89	10.54
Earnings per share, diluted USD per share	15.88	24.39	13.97	4.77	8.84	10.46
Weighted average shares, basic millions of shares	97	97	91	87	84	83
Weighted average shares, diluted millions of shares	98	98	92	88	84	84

Fiscal years (LH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2021Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	1,321	1,473	430	537	1,519	532
Accounts receivable	2,480	2,262	2,222	1,913	1,944	2,104
Inventory	423	401	471	475	493	535
Prepaid and other current assets	—	—	—	—	698	693
Total current assets	5,125	5,331	4,625	3,765	4,807	4,021
Property and equipment, net	2,730	2,815	2,956	2,912	3,045	3,082
Right-of-use asset	790	746	774	737	785	804
Goodwill	7,752	7,959	8,121	6,143	6,370	6,790
Total assets	20,072	20,385	20,155	16,725	18,379	18,393
Accounts payable	639	621	935	828	876	841
Accrued liabilities	1,358	1,404	1,069	804	871	848
Current portion of long-term debt	—	—	—	—	1,000	500
Total current liabilities	3,079	2,783	3,079	3,225	3,330	2,824
Long-term debt	5,419	5,417	5,039	4,055	5,331	5,085
Lease liability, non-current	678	643	680	649	676	683
Total liabilities	10,691	10,091	10,040	8,835	10,313	9,756
Retained earnings	9,402	10,457	10,582	7,888	8,303	8,640
Total stockholders' equity	9,360	10,273	10,097	7,875	8,052	8,620
Total liabilities and equity	20,072	20,385	20,155	16,725	18,379	18,393
Common shares outstanding (cover page) millions of shares	98	≈93	≈89	≈84	84	82

≈ Rounded on cover: the filing states this count rounded, and it sits more than 1% off the weighted shares for the period.

Fiscal years (LH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2021Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	1,556	2,377	1,279	418	746	877
Stock-based compensation	112	154	144	129	117	126
Depreciation and amortization	625	745	634	577	644	681
Net cash from operating activities	2,135	3,110	1,956	1,328	1,586	1,641
Purchases of property and equipment	382	460	482	454	490	435
Net cash from investing activities	(643)	(885)	(1,652)	(1,172)	(1,367)	(1,194)
Share repurchases	100	1,669	1,100	1,000	250	450
Dividends paid	—	—	195	254	243	241
Proceeds from long-term debt	0	1,000	0	—	—	—
Net cash from financing activities	(517)	(2,066)	(1,322)	(59)	780	(1,457)
Net change in cash	983	152	(1,043)	107	982	(986)

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Labcorp Holdings	262	3,810	564*	81.2M	—	Q3 FY26 10-QSep 30, 2026
Natera	1,092	753	55*	144.1M	—	Q2 FY26 10-QJun 30, 2026
Quest Diagnostics	797	3,097	611*	110.0M	—	Q3 FY26 10-QSep 30, 2026
Exact Sciences	956	878*	152*	190.9M	—	Q4 FY25 10-KDec 31, 2025
Guardant Health	1,053	335	(58)*	134.2M	18.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.